Design of α-S-Neoglycopeptides Derived from MUC1 with a Flexible and Solvent-Exposed Sugar Moiety
about
Site-Selective Modification of Proteins with Oxetanes.Principles of mucin structure: implications for the rational design of cancer vaccines derived from MUC1-glycopeptides.Heterovalent Glycodendrimers as Epitope Carriers for Antitumor Synthetic Vaccines.Rapid phenolic O-glycosylation of small molecules and complex unprotected peptides in aqueous solvent
P2860
Design of α-S-Neoglycopeptides Derived from MUC1 with a Flexible and Solvent-Exposed Sugar Moiety
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Design of α-S-Neoglycopeptides ...... d Solvent-Exposed Sugar Moiety
@ast
Design of α-S-Neoglycopeptides ...... d Solvent-Exposed Sugar Moiety
@en
Design of α-S-Neoglycopeptides ...... d Solvent-Exposed Sugar Moiety
@nl
type
label
Design of α-S-Neoglycopeptides ...... d Solvent-Exposed Sugar Moiety
@ast
Design of α-S-Neoglycopeptides ...... d Solvent-Exposed Sugar Moiety
@en
Design of α-S-Neoglycopeptides ...... d Solvent-Exposed Sugar Moiety
@nl
prefLabel
Design of α-S-Neoglycopeptides ...... d Solvent-Exposed Sugar Moiety
@ast
Design of α-S-Neoglycopeptides ...... d Solvent-Exposed Sugar Moiety
@en
Design of α-S-Neoglycopeptides ...... d Solvent-Exposed Sugar Moiety
@nl
P2093
P50
P356
P1476
Design of α-S-Neoglycopeptides ...... d Solvent-Exposed Sugar Moiety
@en
P2093
Alberto Avenoza
Ismael Compañón
Jorge Castro-Loṕez
María M Zurbano
Víctor Rojas-Ocáriz
P304
P356
10.1021/ACS.JOC.6B00833
P407
P50
P577
2016-06-28T00:00:00Z